Compare Moderna, Inc. (MRNA) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Financial Select Sector SPDR Fund — how do they compare? Moderna, Inc. trades at $136.84 (market cap $54.14B), while Financial Select Sector SPDR Fund trades at $57.23. The key difference: Financial Select Sector SPDR Fund is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | XLF | |
|---|---|---|
Market Cap | $54.14B | — |
Sector | Health | — |
52-Week High | $174.38 | $58.55 |
52-Week Low | $22.36 | $47.80 |
Enterprise Value | $50.29B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $140.33, down 3.59% on the day, amid mixed signals. The stock has seen volatility, with a 143% surge over the past month driven by positive cancer vaccine trial results (Fox Business, 2026-09-06), but faces headwinds from declining revenue and persistent net losses. Technical analysis shows a bullish overall signal, with support at $138 and resistance at $145, while fundamentals reveal a challenging profit margin of -142.58% for 2026.
The outlook hinges on pipeline successes, particularly in oncology, but high valuation ratios and competitive pressures pose risks. Analyst consensus is cautious, with a $90.08 price target, reflecting skepticism despite recent clinical milestones. Investors should weigh innovation potential against financial sustainability and market sentiment shifts.
XLF trades at $57.30, down 1.38% amid neutral technical signals with mixed moving averages and oscillators. The ETF consolidates near key support at $57 with resistance at $58. Recent news highlights fund manager rotation into financial stocks in Q2 2026 as rising rates benefit banks and insurers, though year-to-date performance remains modest.
Outlook hinges on interest rate trends favoring financials, with competitive expense ratios attracting investors. Risks include economic sensitivity and sector concentration. Wall Street sentiment is balanced with technical indicators suggesting near-term consolidation around current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
